Cat. No. 1437
Chemical Name: O-(Octahydro-4,7-methano-1H-inden-5
Biological ActivitySelective competitive phosphatidyl choline-specific phospholipase C (PC-PLC) inhibitor (Ki = 6.4 μM); antiviral and antitumor agent. Suppresses LPS- and IFNγ-induced NO production (IC50 = 20 mg/ml) and blocks oxidative glutamate toxicity in nerve cells. Antioxidant in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Zhou et al (2001) D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. J.Pharmacol.Exp.Ther. 298 103. PMID: 11408530.
Li et al (1998) Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc.Natl.Acad.Sci.U.S.A. 95 7748. PMID: 9636222.
Amtmann (1996) The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp.Clin.Res. 22 287. PMID: 9034754.
Tschiakowsky et al (1994) Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609). Br.J.Pharmacol. 113 664. PMID: 7532078.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for D609 include:
Navratil et al (2014) Francisella tularensis LVS induction of prostaglandin biosynthesis by infected macrophages requires specific host phospholipases and lipid phosphatases. Infect Immun 82 3299. PMID: 24866789.
Do you know of a great paper that uses D609 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: D609, supplier, Selective, PC-PLC, inhibitors, inhibits, Phospholipases, C, Esterases, Tocris Bioscience, Phospholipase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Selective endothelial lipase inhibitor; orally bioavailable
September 14, 2016